Peter W. Horby British infectious disease epidemiologist
Horby, Peter.
Horby, Peter, Tropengeneeskunde, infectieziekten
VIAF ID: 173465108 (Personal)
Permalink: http://viaf.org/viaf/173465108
Preferred Forms
-
-
100 1 _ ‡a Horby, Peter
-
-
100 1 _ ‡a Horby, Peter
-
100 1 _ ‡a Horby, Peter
-
-
-
100 0 _ ‡a Peter W. Horby ‡c British infectious disease epidemiologist
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Atlas of human infectious diseases |
![]() ![]() ![]() ![]() ![]() ![]() |
Increase in Enterovirus D68 Infections in Young Children, United Kingdom, 2006-2016 |
![]() |
Influenza A(H1N1)pdm09 but not A(H3N2) virus infection induces durable sero-protection: results from the Ha Nam Cohort |
![]() |
Influenza A H5N1 and HIV co-infection: case report. |
![]() |
Influenza infection rates, measurement errors and the interpretation of paired serology |
![]() |
International Biological Reference Preparations for Epidemic Infectious Diseases |
![]() |
International Survey to Establish Prioritized Outcomes for Trials in People With Coronavirus Disease 2019 |
![]() |
Investigation of dengue and Japanese encephalitis virus transmission in Hanam, Viet Nam. |
![]() |
Isolation of viable Zika virus from spermatozoa. |
![]() |
Lack of SARS transmission among public hospital workers, Vietnam |
![]() |
Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE) |
![]() |
Lassa fever in pregnancy: a systematic review and meta-analysis |
![]() |
Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study |
![]() |
Local, national, and regional viral haemorrhagic fever pandemic potential in Africa: a multistage analysis |
![]() |
Long-term outcomes of patients with Streptococcus suis infection in Viet Nam: A case-control study |
![]() |
Mapping the zoonotic niche of Ebola virus disease in Africa |
![]() |
Measuring mosquito-borne viral suitability in Myanmar and implications for local Zika virus transmission |
![]() |
Migration and persistence of human influenza A viruses, Vietnam, 2001-2008. |
![]() |
Modelling the progression of pandemic influenza A (H1N1) in Vietnam and the opportunities for reassortment with other influenza viruses |
![]() |
Modernising epidemic science: enabling patient-centred research during epidemics |
![]() |
A national outbreak of multi-resistant Salmonella enterica serovar Typhimurium definitive phage type |
![]() |
Non-pharmaceutical interventions for pandemic influenza, national and community measures. |
![]() |
A novel coronavirus outbreak of global health concern |
![]() |
Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections |
![]() |
Online video sharing and patients' privacy. |
![]() |
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial |
![]() |
Open source clinical science for emerging infections |
![]() |
Pandemic H1N1 virus transmission and shedding dynamics in index case households of a prospective Vietnamese cohort |
![]() |
Performance of different clinical trial designs to evaluate treatments during an epidemic |
![]() |
Person-to-person transmission of influenza A (H5N1) |
![]() |
Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients |
![]() |
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza |
![]() |
PHLS overview of communicable diseases 1999. |
![]() |
Population susceptibility to a variant swine-origin influenza virus A(H3N2) in Vietnam, 2011-2012 |
![]() |
The potential for a controlled human infection platform in Singapore |
![]() |
Preparedness for admission of patients with suspected Ebola virus disease in European hospitals: a survey, August-September 2014. |
![]() |
Prevalence and determinants of influenza vaccination in Australians aged 40 years and over - a national survey |
![]() |
Priorities, Barriers, and Facilitators towards International Guidelines for the Delivery of Supportive Clinical Care during an Ebola Outbreak: A Cross-Sectional Survey |
![]() |
Progress towards eliminating Hib in Australia: an evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to 30 June 2000. |
![]() |
Prolonged Evolution of Virus-Specific Memory T Cell Immunity after Severe Avian Influenza A (H7N9) Virus Infection |
![]() |
Prospects for emerging infections in East and southeast Asia 10 years after severe acute respiratory syndrome |
![]() |
Quantifying the emergence of dengue inCE OF DENGUE IN HANOI, 1998-2009. |
![]() |
Randomised controlled trials for Ebola: practical and ethical issues |
![]() |
Rapid outbreak sequencing of Ebola virus in Sierra Leone identifies transmission chains linked to sporadic cases |
![]() |
A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks-results from the Lassa fever pilot |
![]() |
Recommendations for enterovirus diagnostics and characterisation within and beyond Europe. |
![]() |
The RECOVERY trial, 2021 |
![]() |
Regulatory and operational complexities of conducting a clinical treatment trial during an Ebola Virus Disease epidemic |
![]() |
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial |
![]() |
Rendering Beef Safe |
![]() |
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score |
![]() |
SARS transmission in Vietnam outside of the health-care setting |
![]() |
SARS: UK public health response--past, present and future. |
![]() |
Science in a crisis: conducting clinical trials in an emergency. |
![]() |
Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review |
![]() |
Seasonality of absolute humidity explains seasonality of influenza-like illness in Vietnam |
![]() |
Sero-Prevalence Surveillance to Predict Vaccine-Preventable Disease Outbreaks; A Lesson from the 2014 Measles Epidemic in Northern Vietnam |
![]() |
Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responses |
![]() |
Social and environmental determinants of malaria in space and time in Viet Nam. |
![]() |
Social contact patterns in Vietnam and implications for the control of infectious diseases |
![]() |
The spectrum of central nervous system infections in an adult referral hospital in Hanoi, Vietnam |
![]() |
Spectrum of Enterovirus Serotypes Causing Uncomplicated Hand, Foot, and Mouth Disease and Enteroviral Diagnostic Yield of Different Clinical Samples |
![]() |
Staphylococcus aureus nasopharyngeal carriage in rural and urban northern Vietnam |
![]() |
Stimulating the development of national Streptococcus suis guidelines in Viet Nam through a strategic research partnership |
![]() |
Strengthening preparedness for (re-) emerging arboviruses in Europe. |
![]() |
Strongyloides stercoralis seroprevalence in Vietnam. |
![]() |
Studying the effectiveness of activated carbon R95 respirators in reducing the inhalation of combustion by-products in Hanoi, Vietnam: a demonstration study |
![]() |
Subclinical avian influenza A(H5N1) virus infection in human, Vietnam |
![]() |
A systematic review of clinical guidelines on the management of acute, community-acquired CNS infections |
![]() |
Teaching research methodology within an Ebola virus outbreak |
![]() |
Temporal and spatial association of Streptococcus suis infection in humans and porcine reproductive and respiratory syndrome outbreaks in pigs in northern Vietnam |
![]() |
Temporal relationship between occurrences of hand, foot and mouth disease, respiratory virus detection and febrile seizures in children in tropical Singapore: a time-series analysis |
![]() |
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial |
![]() |
Towards consensus on correct interpretation of protein binding in plasma and other biological matrices for COVID-19 therapeutic development |
![]() |
Trial design for evaluating novel treatments during an outbreak of an infectious disease |
![]() |
Understanding and managing zoonotic risk in the new livestock industries |
![]() |
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis |
![]() |
Using computer simulations to compare pertussis vaccination strategies in Australia. |
![]() |
Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000 |
![]() |
Variant Creutzfeldt-Jakob disease: an unfolding epidemic of misfolded proteins |
![]() |
What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? |
![]() |